Archives
Mutational Landscape of Myeloma Cell Lines: Implications for
2026-07-24
This study delivers the first comprehensive exome-wide characterization of human multiple myeloma cell lines (HMCLs), revealing recurrent mutations, key driver genes, and pathway alterations associated with tumor progression and drug resistance. The findings provide a critical framework for selecting cellular models and interpreting drug response in myeloma research.
I-BET-762 BET Inhibitor: Optimizing Ferroptosis and Inflamma
2026-07-23
I-BET-762 distinguishes itself as a high-affinity, selective BET inhibitor, enabling robust and reproducible workflows in cancer and inflammation research. Leveraging new evidence, this guide offers actionable protocols, troubleshooting insights, and assay enhancements for researchers pursuing ferroptosis and transcriptional regulation studies.
Efficient iPSC Differentiation to Retinal Ganglion Cells via
2026-07-23
Chavali et al. present a chemically defined protocol utilizing dual SMAD and Wnt inhibition to reproducibly differentiate human iPSCs into retinal ganglion cells (RGCs) with high purity. This approach addresses previous challenges of variability and low yield, providing a valuable tool for glaucoma research and regenerative applications.
Torin2: Precision mTOR Inhibitor Workflows for Cancer Resear
2026-07-22
Torin2 delivers unmatched potency and selectivity as an mTOR inhibitor, empowering cancer researchers to dissect PI3K/Akt/mTOR signaling and regulated apoptosis with reproducible, quantitative rigor. Unique protocol enhancements and troubleshooting strategies ensure reliable mTOR pathway inhibition from cell-based to in vivo tumor models.
Plant Exosome-Like Nanovesicles Alleviate Testicular Injury
2026-07-22
This study demonstrates that exosome-like nanovesicles derived from Cistanche deserticola can mitigate cyclophosphamide-induced testicular damage by targeting Sertoli cell cycle arrest. The findings highlight a novel plant-based intervention for male reproductive protection and provide mechanistic insight into miRNA-mediated cell cycle regulation.
Capsaicin-Induced Autophagy Preserves BMSC Function Under St
2026-07-21
This study demonstrates that capsaicin activates autophagy in bone marrow stromal cells (BMSCs) under oxidative stress, improving their viability and osteogenic differentiation by modulating TRPV1 and inhibiting the PI3K/AKT/mTOR pathway. The findings highlight a potential therapeutic approach for osteoporosis via targeted regulation of cellular stress responses and autophagy.
Balsalazide Disodium Dihydrate: Precision in Inflammation Re
2026-07-21
Balsalazide Disodium Dihydrate enables targeted, reproducible modeling of colonic inflammation with robust performance in both mechanistic and translational workflows. Its water solubility, unique prodrug activation, and compatibility with radiolabeling and immunology assays position it as a cornerstone for advanced ulcerative colitis research.
KPT-330 (Selinexor): Optimizing Cancer and Osteoclast Assays
2026-07-20
KPT-330 (Selinexor), a selective CRM1 inhibitor from APExBIO, sets a new benchmark in both oncology and osteoclast-targeted research by enabling precise nuclear export inhibition. This article details actionable workflows, comparative advantages, and troubleshooting insights to empower reliable apoptosis and bone remodeling assays.
AZD-3463: Advanced ALK/IGF1R Inhibition and Pathway Crosstal
2026-07-20
Explore how AZD3463, a potent ALK/IGF1R inhibitor, reshapes neuroblastoma research by targeting key signaling pathways. This article uniquely examines pathway crosstalk and practical insights for translational assay design.
circRNA hsa_circ_0136666 Drives Immune Escape in Gastric Can
2026-07-19
Miao et al. reveal that hsa_circ_0136666 promotes gastric cancer progression and immune evasion by regulating the miR-375/PRKDC axis and enhancing PD-L1 phosphorylation. These findings establish a new molecular circuit for tumor immune escape and suggest avenues to improve immunotherapy efficacy.
Disrupting G4–STAT1 to Enhance Olaparib-Induced Cancer Cell
2026-07-18
This study identifies a novel mechanism by which G-quadruplex (G4) structures in the BLM promoter region recruit STAT1 to drive BLM overexpression in cancer cells. The authors show that natural alkaloids disrupt this interaction, and, when combined with Olaparib, synergistically increase cancer cell death by intensifying DNA damage—a finding with direct implications for targeted therapy design.
3-Deazaadenosine Hydrochloride in Methylation Pathway Resear
2026-07-17
3-Deazaadenosine hydrochloride empowers researchers to dissect methylation-driven processes in liver fibrosis and inflammation, thanks to its potent SAHH inhibition and high solubility. This article translates the latest mechanistic insights into practical workflows, troubleshooting strategies, and protocol enhancements for high-impact hepatic stellate cell and methyltransferase studies.
SCH772984: ERK1/2 Inhibition for Overcoming Tumor Radioresis
2026-07-17
Explore how the ERK1/2 inhibitor SCH772984 enables advanced MAPK/ERK pathway inhibition to combat tumor radioresistance—including in challenging BRAF, NRAS, and KRAS mutant models. This article delivers a deeper mechanistic and translational perspective beyond existing content.
JNJ-26481585 (Quisinostat): Protocols for Advanced HDAC Inhi
2026-07-16
JNJ-26481585 (Quisinostat) stands out as a second-generation HDAC inhibitor, offering robust epigenetic modulation and apoptosis induction, particularly in drug-resistant cancer models. This article translates the latest TRIM21-ERK1/2 research into actionable workflows, troubleshooting strategies, and protocol enhancements for maximizing the compound’s impact in translational oncology.
MK-1775 (Wee1 Kinase Inhibitor): Optimizing Cancer Workflows
2026-07-16
MK-1775 (Wee1 kinase inhibitor) from APExBIO empowers researchers to abrogate the G2 DNA damage checkpoint and sensitize p53-deficient tumor cells to DNA-damaging agents. This guide delivers actionable workflows, troubleshooting strategies, and insights for maximizing reproducibility and translational impact in preclinical cancer research.
607 records 14/41 page Previous Next First page 上5页 1112131415 下5页 Last page